儿童、青少年桥本氏甲状腺炎125例特点分析
被引量：2
摘要
慢性淋巴细胞性甲状腺炎（ＣＬＴ）亦称为桥本氏甲状腺炎，为一种自身免疫性疾病。是儿童、青少年甲状腺肿、甲状腺功能减低最常见的原因之一。过去对本病的认识不足，对这方面的报道亦不多见，临床上常误诊为单纯性甲状腺肿、原发性甲亢、甲状腺瘤或家族性甲状腺肿、甲状...
出处
《现代康复》
CSCD
1998年第11期1274-1275,共2页
Modern Rehabilitation
同被引文献15
-
1Krohne TU, Eter N, Holz FG. Meyer CH Intraoeular pharmacokinetics of bevacizumab after a single intravitreal injection in humans [J]. Am J Ophthalmol,2008,146 : 508-512.
-
2Bakri SJ, Snyder MR, Reid JM. Pharmacokinetics of intravitreal bevadzumab (Avastin)[J]. Ophthalmology,2007,114:855-859.
-
3Gaudreault J, Fei D, Rusit J. Preclinical pharmacokinetics of Ranibizumab (rhuFabV2) after a single intravitreal administration [J]. Invest Ophthalmol Vis Sci,2005,46:726-33.
-
4Bakri SJ, Snyder MR, Reid JM. Pharmacokinetics of intravitreal ranibizumab (Lucentis)[J]. Ophthalmology, 2007,114:2179-2182.
-
5Bakri SJ, Snyder MR, Reid JM. Pharmacokinetics of intravitreal bevacizumab( Avastin)[J]. Ophthalmology, 2007,114:855-859.
-
6Rosenfeld PJ, Brown DM, Heier JS, etal. Ranibizumab for neovascular age-related macular degeneration[J]. New Engl Med, 2006, 355 : 1419-1431.
-
7Brown DM, Kaiser PK, Michels M,et al. Ranibizurnab versus verteporfin for neovascular age-related macular dageneration[J]. New Engl Med,2006,355 : 1432-1444.
-
8Meyer CH, Mermel S, Horle S,et al. Visual hallucinations after intravitreal injection of bevacizumab in vascular age-related maeular degeneration[J]. Am J Ophthalmol, 2007,143(1) :169-170.
-
9Gamulescu MA, Framme C, Sachs H. RPE-rip after intravitreal bevacizumab (Avastin) treatment for vascularised PED secondary to AMD[J]. Graefes Arch Clin Exp Ophthalmot, 2007, 245 (7): 1037-1040.
-
10Gibran SK, Sachdev A, Stappler T,et al. Histological findings of a choroidal neovascular membrane removed at the time of macular translocation in a patient previously treated with intravitreal bevacizumab treatment (Avastin) [J]. Br J Ophthalmol, 2007, 91 (5): 602-604.
-
1毛萌,袁大华.儿童桥本氏甲状腺炎诊断与治疗(附17例报告)[J].中国医刊,1999,34(7):36-37. 被引量：1
-
2刘振玲,杜华.儿童桥本氏甲状腺炎4例报告[J].广西医学,1997,19(2):303-305.
-
3董文斌,冉隆瑞,肖大成.NO介导细胞因子失衡致儿童慢性淋巴细胞性甲状腺炎发病的作用[J].细胞与分子免疫学杂志,2000,16(1):49-50. 被引量：4
-
4曾纪骅,贾宏丽,季志英,蔡乐雯,袁虹.儿童慢性淋巴细胞性甲状腺炎临床特点及转归[J].中华儿科杂志,1996,34(1):5-7. 被引量：10
-
5刘霞,徐刚,张琴,刘小红.儿童甲状腺疾病血浆ET-1水平探讨[J].中国妇幼保健,2005,20(12):1505-1506.
-
6游欢庆,金献江,项如莲.儿童慢性淋巴细胞性甲状腺炎12例临床分析[J].浙江医学,2001,23(5):287-288. 被引量：1
-
7董文斌,肖大成,冉隆瑞,唐章华.白细胞介素10对儿童慢性淋巴细胞性甲状腺炎γ干扰素/白细胞介素4失衡的影响[J].中华儿科杂志,2000,38(2):97-99. 被引量：3
-
8史春华.儿童桥本氏甲状腺炎4例临床特征及文献复习[J].中国继续医学教育,2016,8(4):138-139. 被引量：2
-
9尹福新,于吉财.桥本氏甲状腺炎58例手术治疗分析[J].中国误诊学杂志,2008,8(6):1432-1433.
-
10甘波,刘爱琳,曾明辉,李利.儿童桥本氏甲状腺炎16例临床分析[J].中国医师杂志,1999,1(4):34-34.
